Literature DB >> 1651243

Purification and characterisation of the insulin-stimulated protein kinase from rabbit skeletal muscle; close similarity to S6 kinase II.

A Lavoinne1, E Erikson, J L Maller, D J Price, J Avruch, P Cohen.   

Abstract

The insulin-stimulated protein kinase (ISPK) was purified over 50,000-fold from extracts of rabbit skeletal muscle by a procedure involving chromatography on phosphocellulose, fractionation with ammonium sulphate, and further chromatography on DEAE-cellulose, phenyl-Superose, Mono S and Mono Q. About 10 micrograms enzyme was isolated from 800 g muscle (one rabbit) in four days with an overall recovery of 5%. The purified enzyme showed a single protein-staining band of apparent molecular mass 91 kDa when analysed by SDS/polyacrylamide gel electrophoresis. The ISPK comigrated during SDS/polyacrylamide gel electrophoresis with the enzyme S6 kinase II from Xenopus eggs, and was recognised in immunoblotting and immunoprecipitation experiments by antibodies raised against S6 kinase II. The substrate specificities of ISPK and S6 kinase II were also very similar and like S6 kinase II, ISPK that had been inactivated by protein phosphatase 2A could be reactivated by incubation with mitogen-activated protein kinase and MgATP. ISPK was distinct from an insulin-stimulated 70-kDa S6 kinase from rat liver in both substrate specificity and immunological cross reactivity. It is concluded that ISPK is closely related in structure to S6 kinase II and may be a mammalian equivalent of this enzyme. The possibility that ISPK is involved in mediating a number of the actions of insulin is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651243     DOI: 10.1111/j.1432-1033.1991.tb16176.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

1.  Multiple roles for protein phosphatase 1 in regulating the Xenopus early embryonic cell cycle.

Authors:  D H Walker; A A DePaoli-Roach; J L Maller
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

Review 2.  Molecular signal integration. Interplay between serine, threonine, and tyrosine phosphorylation.

Authors:  J Posada; J A Cooper
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

3.  The pool of map kinase associated with microtubules is small but constitutively active.

Authors:  M Morishima-Kawashima; K S Kosik
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

4.  Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.

Authors:  T Wada; T Sasaoka; M Funaki; H Hori; S Murakami; M Ishiki; T Haruta; T Asano; W Ogawa; H Ishihara; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 5.  Spatial determinants of specificity in insulin action.

Authors:  C C Mastick; M J Brady; J A Printen; V Ribon; A R Saltiel
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 6.  Protein phosphatase-1 and insulin action.

Authors:  L Ragolia; N Begum
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases.

Authors:  R H Chen; C Sarnecki; J Blenis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini.

Authors:  J R Grove; P Banerjee; A Balasubramanyam; P J Coffer; D J Price; J Avruch; J R Woodgett
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  Increasing cAMP attenuates activation of mitogen-activated protein kinase.

Authors:  B R Sevetson; X Kong; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Abnormal regulation of ribosomal protein S6 kinase by insulin in skeletal muscle of insulin-resistant humans.

Authors:  J Sommercorn; R Fields; I Raz; R Maeda
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.